Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Syndax Pharmaceuticals Inc | 85,095 | reported | 10 Feb 2025 | tx 8+519,588−4,618 |
| Foghorn Therapeutics Inc. | 50,000 | reported | 01 May 2025 | tx 1+50,000 |
| Zymeworks Inc. | 31,000 | reported | 10 Dec 2024 | tx 2+105,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2025 | GRANT_AWARD | Foghorn Therapeutics Inc. | 50,000 | 4.16 USD | deriv |
| 10 Feb 2025 | SALE | Syndax Pharmaceuticals Inc | 4,618 | 15.50 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 23,400 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 18,500 | 0.00 USD | |
| 05 Feb 2025 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 110,500 | 14.65 USD | deriv |
| 10 Dec 2024 | GRANT_AWARD | Zymeworks Inc. | 31,000 | 0.00 USD | deriv |
| 02 Apr 2024 | GRANT_AWARD | Zymeworks Inc. | 74,000 | 0.00 USD | deriv |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 34,688 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 13,125 | 0.00 USD | |
| 07 Feb 2024 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 69,375 | 22.28 USD | deriv |
| 10 Apr 2023 | GRANT_AWARD | Syndax Pharmaceuticals Inc | 250,000 | 19.35 USD | deriv |